Monday, September 14, 2026

OpenAI CEO Sam Altman to Meet Kakao During Korea Visit, With Naver Talks Also Expected

Sam Altman of OpenAI will meet Kakao and speak at Samsung, focusing on AI collaboration and advancements during his South Korea visit.

LG Innotek Targets Flawless AI Vision with Intel-Powered Upgrade

LG Innotek partners with Intel to enhance AI vision inspection, aiming for nearly 100% accuracy in manufacturing processes.

Lee Jung-hoo Hits Two Home Runs: What This Means for His MLB Future in 2026

Lee Jung-hoo showcased his hitting prowess with three hits, including multiple home runs, for the San Francisco Giants.

Tag: Cartistem

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

CARTISTEM vs. Traditional Treatments: What Makes Medipost’s Stem Cell Therapy a Game-Changer?

Medipost to commercialize CARTISTEM in Japan using domestically produced media, enhancing supply chain stability and competitiveness.

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial

Medipost's CARTISTEM therapy shows significant efficacy in Phase 3 trials for knee osteoarthritis in Japan, enhancing global competitiveness.

Medipost’s CARTISTEM® Completes Phase 3 Trials in Japan: What This Means for Knee Osteoarthritis Treatment

Medipost completes Phase 3 trial for CARTISTEM in Japan, targeting knee osteoarthritis treatment and planning U.S. trial enrollment soon.

Medipost’s Cartistem: Achieving 3000 Knee Cartilage Restoration Surgeries – A Game Changer for Osteoarthritis Treatment

Medipost's Cartistem therapy reaches 3,000 procedures for cartilage restoration, proving its safety and efficacy for knee osteoarthritis.

U.S. Surgeons Get Hands-On With Korea’s Game-Changing Stem Cell Therapy

Medipost's Cartistem® training program for U.S. orthopedic specialists enhances global collaboration and prepares for Phase 3 trials.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.